Fuchs Martin, Drexler Helmut
Abteilung Kardiologie und Angiologie, Zentrum Innere Medizin, Medizinische Hochschule Hannover.
Herz. 2004 Dec;29(8):782-7. doi: 10.1007/s00059-004-2630-0.
For a long time chronic heart failure was seen as a purely myocardial problem, which is characterized by symptoms in consequence of an impaired contractility. Later on it became apparent that chronic heart failure is at least in part characterized by activation of the neuroendocrine system, in particular the sympathetic nervous system and the renin-angiotensin-aldosterone system. This neuroendocrine system is an important system that is not only responsible for symptoms but probably very important for the development and progression of heart failure and therefore relevant to the prognosis of these patients. Apart from this neuroendocrine activation heart failure is characterized by an inflammatory component. The mechanisms of inflammation seem to play an important role in the process of left ventricular remodeling including structural and functional changes of the myocardium which are not only in part responsible for the development of symptoms but also for the progression of disease. It turns out that pathophysiological consequences of activated inflammation are deleterious in the long term, but may provide transient protective effects in the acute stage of ischemia. Regarding clinical trials it can be assumed that general inhibition of the inflammation process by inhibition of tumor necrosis factor-(TNF-)alpha does not necessarily exert favorable effects.
长期以来,慢性心力衰竭一直被视为纯粹的心肌问题,其特征是由于心肌收缩力受损而出现症状。后来发现,慢性心力衰竭至少部分特征是神经内分泌系统激活,特别是交感神经系统和肾素 - 血管紧张素 - 醛固酮系统。这个神经内分泌系统是一个重要系统,不仅导致症状出现,而且可能对心力衰竭的发生和发展非常重要,因此与这些患者的预后相关。除了这种神经内分泌激活外,心力衰竭还具有炎症成分。炎症机制似乎在左心室重塑过程中起重要作用,包括心肌的结构和功能变化,这些变化不仅部分导致症状出现,还导致疾病进展。事实证明,激活炎症的病理生理后果从长远来看是有害的,但在缺血急性期可能提供短暂的保护作用。关于临床试验,可以假设通过抑制肿瘤坏死因子 -α 来全面抑制炎症过程不一定会产生有利影响。